Blog
  • Omnichannel
  • Oncology
  • Conferences
  • Media Tracking
  • Ferma.AI
  • Launch Excellence
  • HCP-PT
  • Talent Community

Covid-19

A collection of 15 posts

Committing To Support COVID-19 Relief and Rehabilitation
Covid-19

Committing To Support COVID-19 Relief and Rehabilitation

Seeing an unprecedented threat to public health and the livelihood of millions, we wanted to get directly involved and do our part in aiding the country’s recovery. To achieve this, ZoomRx pledged a relief fund dedicated solely toward COVID-19 response and recovery.

  • Sai Keerthana
    Sai Keerthana
4 min read
Returning to In-Person Promotion: Physician Expectations for Sales Rep Vaccination
Customer Engagement

Returning to In-Person Promotion: Physician Expectations for Sales Rep Vaccination

As the COVID-19 vaccine rollout continues in the United States, sales teams across the pharmaceutical industry are considering how and when to increase the volume of in-person promotion.

  • Ty Harkness
    Ty Harkness
  • Karni Medh
    Karni Medh
  • Yashaswi Jajodia
5 min read
COVID-19 Impact: The Future of In-person and Omni-channel Promotion
Covid-19

COVID-19 Impact: The Future of In-person and Omni-channel Promotion

The COVID-19 pandemic led to significant changes in the way pharma engaged with healthcare practitioners (HCPs). To better understand these trends, ZoomRx analyzed over 20,000 sales rep interactions during the COVID-19 pandemic,

  • Andrew Yukawa
    Andrew Yukawa
  • Ty Harkness
    Ty Harkness
2 min read
After Q4 Earnings Calls: Comparing Industry Outlook and Physician Perspectives
Covid-19

After Q4 Earnings Calls: Comparing Industry Outlook and Physician Perspectives

During Q4 earnings calls, biopharmaceutical companies reflected on the cumulative impact of the COVID-19 pandemic. An assessment of US-based physician sentiment (n=62) provides a useful ‘on-the-ground’ perspective to further examine these issues.

  • Kat Lynch
    Kat Lynch
  • Monique J Menezes
    Monique J Menezes
  • Melissa Weinstein
    Melissa Weinstein
4 min read
Genome editing using CRISPR and gene therapy captured attention during this year’s fully virtual ASH annual meeting.
Conferences

Genome editing using CRISPR and gene therapy captured attention during this year’s fully virtual ASH annual meeting.

Early stage data showcasing the potential of both genome editing using CRISPR and gene therapy in non-malignant hematological disorders captured attention during this year’s fully virtual ASH annual meeting. A highlight of

  • Laurence Meloty-Kapella
    Laurence Meloty-Kapella
  • Surya Kani
    Surya Kani
5 min read
Q3 Earnings Calls Presented a Case for Cautious Optimism
Covid-19

Q3 Earnings Calls Presented a Case for Cautious Optimism

Having weathered many challenges in Q2 2020, biopharmaceutical firms, by and large, presented a case for optimism during Q3 2020 earnings calls. However, alongside this optimistic outlook were a number of voices expressing

  • Kat Lynch
    Kat Lynch
  • Monique J Menezes
    Monique J Menezes
  • Anu Mohan
    Anu Mohan
4 min read
The Benefits of Video-Conferences over Phone Calls for Oncology Sales Interactions
Customer Engagement

The Benefits of Video-Conferences over Phone Calls for Oncology Sales Interactions

During the COVID-19 pandemic, video conferences have proven to drive much better results compared to phone calls for oncology sales interactions.

  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Ty Harkness
    Ty Harkness
  • Vidhya Hariharan
    Vidhya Hariharan
3 min read
Q2 Earnings Calls Provide Insight on the Future of In-Person Promotional Activity
Covid-19

Q2 Earnings Calls Provide Insight on the Future of In-Person Promotional Activity

A return to pre-pandemic levels of in-person promotional activity looks increasingly uncertain in H2 2020. Given this uncertainty, pharmaceutical manufacturers, from diversified, multinational firms to more focused, growth-stage companies are navigating the complexities

  • Kat Lynch
    Kat Lynch
  • Anu Mohan
    Anu Mohan
  • Monique J Menezes
    Monique J Menezes
3 min read
Impact of COVID-19 on Therapeutic Approaches to Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
Covid-19

Impact of COVID-19 on Therapeutic Approaches to Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder

Understand how neurology departments across the US and Canada are rapidly adapting their clinical care delivery systems to minimize risk of SARS-CoV-2 transmission.

  • Brittany Gazdag
    Brittany Gazdag
  • Aditya Ravi Kumar
    Aditya Ravi Kumar
4 min read
COVID-19: Physician Perspective on Efforts to Address Health Inequity
Covid-19

COVID-19: Physician Perspective on Efforts to Address Health Inequity

Evidence shows that the ongoing COVID-19 pandemic disproportionately impacts Black Americans. Here are some recommendations from physicians to advocate for heath equity.

  • Melissa Green
    Melissa Green
  • Andrew Yukawa
    Andrew Yukawa
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Subhadhra Padmanabhan Dhandapani
    Subhadhra Padmanabhan Dhandapani
4 min read
Q1 Earnings Calls Provide Insight into the Future of In-Person Promotional Activity
Covid-19

Q1 Earnings Calls Provide Insight into the Future of In-Person Promotional Activity

Pharmaceutical manufacturers, from diversified, multinational firms to focused, growth-stage companies are adapting to the reality of COVID-19. Recent Q1 investor calls provide insight into both the impact of the pandemic thus far on

  • Anu Mohan
    Anu Mohan
  • Kat Lynch
    Kat Lynch
3 min read
Telemedicine and Breast Cancer Patient Care during the COVID-19 Pandemic: Oncologists' Perspective
Covid-19

Telemedicine and Breast Cancer Patient Care during the COVID-19 Pandemic: Oncologists' Perspective

COVID-19 has served as a catalyst for the rapid uptake of telemedicine across a range of therapeutic categories. Initially, physicians adopted telemedicine, despite uncertainty surrounding reimbursement, in order to ensure the safety of

  • Kinga Zapert
    Kinga Zapert
  • Anu Mohan
    Anu Mohan
  • Sangeetha Govindarajan
    Sangeetha Govindarajan
  • Natielle Lohman
    Natielle Lohman
3 min read
COVID-19 Impact on US Commercial Payers
Covid-19

COVID-19 Impact on US Commercial Payers

Throughout the COVID outbreak, health plans have collectively gone to great lengths to provide coverage in an urgent and unexpected situation. Plans have rapidly adapted to current healthcare needs...

  • Ben Druck
    Ben Druck
  • Andrew Yukawa
    Andrew Yukawa
  • Anirudh Vaidhyaa
    Anirudh Vaidhyaa
4 min read
COVID-19: Impact on Healthcare Practices and Treatment Decisions
Covid-19

COVID-19: Impact on Healthcare Practices and Treatment Decisions

The evolving COVID-19 pandemic is causing enormous impact on individuals and the healthcare system. Increasingly, it is also clear that COVID-19 has broad-ranging effects on our workplaces, our economy, and our social interactions.

  • Brittany Gazdag
    Brittany Gazdag
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Molly Osmulski
    Molly Osmulski
  • Hari Vignesh
    Hari Vignesh
3 min read
AAN 2020 Abstracts Released - What We're Watching in Multiple Sclerosis
Conferences

AAN 2020 Abstracts Released - What We're Watching in Multiple Sclerosis

As of March 13, the AAN annual meeting has been cancelled due to the ongoing global COVID-19 (Coronavirus) pandemic. We'll be keeping a close eye on any plans to hold events digitally and

  • Brittany Gazdag
    Brittany Gazdag
3 min read

All rights reserved ZoomRx - 2020.   Privacy Policy


HOME
PERSPECTIVES
PANELISTS
CAREERS